JAC Advance Access originally published online on March 10, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2004) 53, 584-591
© 2004 The British Society for Antimicrobial Chemotherapy
Analysis of AmpC ß-lactamase expression and sequence in biochemically atypical ceftazidime-resistant Enterobacteriaceae from paediatric patients
Bristol Centre for Antimicrobial Research and Evaluation, Department of Pathology & Microbiology, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1TD, UK
Received 5 September 2003; returned 16 November 2003; revised 18 December 2003; accepted 23 January 2004
Objectives: To analyse the variation of ampC ß-lactamase gene sequence and expression in biochemically atypical Enterobacteriaceae isolates, and to identify them definitively.
Methods: ß-Lactamase gene-containing recombinant plasmids transformed into Escherichia coli were selected using ampicillin. PCR analysis was used to locate specific ampC and 16S rRNA genes, and the amplicons were sequenced. Random amplified polymorphic DNA PCR was used to group isolates and API 20E biochemical profiling was used to identify them putatively.
Results: Of 50 ceftazidime-resistant clinical Enterobacteriaceae isolates, 36 were identified (>95% confidence)using API 20E test stripsas being organisms known to express inducible class C ß-lactamases (Citrobacter freundii, Enterobacter cloacae, Morganella morganii or Hafnia alvei). The rest were biochemically atypical. Of these, isolate I113, putatively identified as E. coli, possesses a chromosomally encoded ampC which differs by 15% from C. freundii OS60 ampC and by >30% from E. coli ampC. A related ampC gene was found in another seven of the atypical isolates. The use of various identification methods, including ampC sequence analysis, revealed that these I113-like ampC-positive isolates represent Citrobacter murliniae and Citrobacter youngae.
Conclusions: We report sequences for two new Citrobacter spp. ampC genes, and provide evidence that ampC sequencing is a discriminatory method for identifying atypical Citrobacter spp. isolates.
Keywords: Citrobacter, lactamases, overexpression, ceftazidime resistance, phylogeny
* Corresponding author. Tel: +44-117-9287897; Fax: +44-117-9287896; E-mail: Matthewb.Avison{at}bris.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. A. Jacoby AmpC {beta}-Lactamases Clin. Microbiol. Rev., January 1, 2009; 22(1): 161 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Naas, D. Aubert, A. Ozcan, and P. Nordmann Chromosome-Encoded Narrow-Spectrum Ambler Class A {beta}-Lactamase GIL-1 from Citrobacter gillenii Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1365 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. I. Enne, A. A. Delsol, J. M. Roe, and P. M. Bennett Evidence of Antibiotic Resistance Gene Silencing in Escherichia coli. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3003 - 3010. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Gould, A. Okazaki, R. A. Howe, and M. B. Avison Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates J. Antimicrob. Chemother., August 1, 2004; 54(2): 348 - 353. [Abstract] [Full Text] [PDF] |
||||


